On this week’s podcast, editors Shawn Schmitt and David Filmore discuss “The Gray Sheet” analysis of where things stand with FDA’s premarket review performance three years in to the MDUFA III user fee program.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
